Financhill
Back

SpringWorks Therapeutics Vs. Arvinas Industry Stock Comparison

Sell
44

SWTX
SpringWorks Therapeutics

Last Price:
36.67
Seasonality Move:
2.19%
Sell
27

ARVN
Arvinas

Last Price:
24.94
Seasonality Move:
10.67%
Sell
44
SpringWorks Therapeutics (SWTX) is a Sell

Is SpringWorks Therapeutics a Buy, Sell or Hold?

  • The current SpringWorks Therapeutics [SWTX] share price is $36.67. The Score for SWTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • SWTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Arvinas (ARVN) is a Sell

Is Arvinas a Buy, Sell or Hold?

  • The current Arvinas [ARVN] share price is $24.94. The Score for ARVN is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ARVN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SWTX Stock Price Chart

What is SpringWorks Therapeutics's stock price today?

  • The SpringWorks Therapeutics share price today is $36.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.

ARVN Stock Price Chart

What is Arvinas's stock price today?

  • The Arvinas share price today is $24.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARVN is experiencing slight selling pressure.

SWTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.49 Sell
Relative Strength Index (14 RSI): 33.65 Sell
Chaikin Money Flow: -387817 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.07 - 43.51) Sell
Bollinger Bands (100): (41.63 - 49.13) Sell

ARVN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.23 Sell
Relative Strength Index (14 RSI): 27.4 Sell
Chaikin Money Flow: -140921 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.08 - 34.12) Sell
Bollinger Bands (100): (31.23 - 45.81) Sell

SWTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39 Sell
20-day SMA: 40.65 Sell
50-day SMA: 42.6 Sell
200-day SMA: 36.84 Sell
8-day EMA: 38.8 Sell
20-day EMA: 40.32 Sell
50-day EMA: 42.28 Sell
200-day EMA: 39.01 Sell

ARVN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.4 Sell
20-day SMA: 30.25 Sell
50-day SMA: 32.22 Sell
200-day SMA: 32.29 Sell
8-day EMA: 26.65 Sell
20-day EMA: 28.96 Sell
50-day EMA: 32.3 Sell
200-day EMA: 33.81 Sell

SpringWorks Therapeutics Earnings Growth & SWTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $1.45 per share.

Arvinas Earnings Growth & ARVN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.21 per share, an increase this year of $1.34 per share, and a decrease next year of $0.84 per share.

SpringWorks Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arvinas Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):